SAVE THE DATE
Precision Medicine is putting the patient at the centre of healthcare and the Bionow Precision Medicine Conference will focus on the impact which this emerging field is having on patients and given the strengths in the North, how are we developing this approach efficiently and sustainably.
Precision Medicine is the next generation of healthcare research that has the potential to provide significant benefits to patients and affect strategic shifts in the way healthcare is delivered. It uses an individual's genetic profile to guide decisions about the prevention, diagnosis, and treatment of disease. Developing new diagnostic tests and expanding the use of biomarkers enables the identification of the molecular cause of disease, and ultimately supports the development of novel, more precisely targeted treatments.
Health Innovation Liverpool, LightOx, Durham University, University of Manchester, Illumina, Kinomica, IBM, Leeds University, Teesside University, Marks & Clerk, QIAGEN, Seda Pharmaceutical Development Services, Newcastle University, Centre for Process Innovation, Medicines Discovery Catapult, Vocal, Leeds Academic Health Partnerships, Phoenix DX, Yourgene Health, Keele University, University of Edinburgh, SRG, Source Bioscience, Quay Pharma, Alderley Park, Bruntwood SciTech, Manchester Biogel, Potter Clarkson, Reprocell, Roche Diagnostics, QuantuMDx, Imagen Therapeutics, Exosome Diagnostics GmbH, Histologix, Pulmobiomed, Vatic, Sai Life Sciences, Amadeus Capital